At Columbia University Medical Center, the Edward S. Harkness Eye Institute's clinic has over 800 genotyped retinitis pigmentosa and juvenile macular degeneration patients awaiting FDA approval of gene therapy approaches to restore their ability to conduct activities of daily living. Visit the Opthalmology Department website to read more about Columbia's efforts in Eye Genetics.
